Vantage Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-289,628
| Closed | -$15.7M | – | 34 |
|
|
2024
Q1 | $15.7M | Sell |
289,628
-27,516
| -9% | -$1.49M | 3.66% | 19 |
|
|
2023
Q4 | $16.3M | Buy |
317,144
+87,961
| +38% | +$4.51M | 3.58% | 21 |
|
|
2023
Q3 | $13.3M | Buy |
229,183
+7,845
| +4% | +$455K | 3.33% | 20 |
|
|
2023
Q2 | $14.2M | Sell |
221,338
-585
| -0.3% | -$37.4K | 3.64% | 22 |
|
|
2023
Q1 | $15.4M | Sell |
221,923
-2,955
| -1% | -$205K | 4.27% | 15 |
|
|
2022
Q4 | $16.2M | Sell |
224,878
-11,315
| -5% | -$814K | 4.17% | 12 |
|
|
2022
Q3 | $16.8M | Sell |
236,193
-1,487
| -0.6% | -$106K | 4.63% | 3 |
|
|
2022
Q2 | $18.3M | Sell |
237,680
-1,966
| -0.8% | -$151K | 5.16% | 2 |
|
|
2022
Q1 | $17.5M | Buy |
239,646
+8,030
| +3% | +$586K | 3.89% | 14 |
|
|
2021
Q4 | $14.4M | Buy |
231,616
+9,725
| +4% | +$606K | 3.19% | 23 |
|
|
2021
Q3 | $13.1M | Buy |
221,891
+8,153
| +4% | +$482K | 3.36% | 21 |
|
|
2021
Q2 | $14.3M | Buy |
213,738
+2,970
| +1% | +$198K | 3.49% | 17 |
|
|
2021
Q1 | $13.3M | Buy |
210,768
+1,875
| +0.9% | +$118K | 3.4% | 16 |
|
|
2020
Q4 | $13M | Buy |
208,893
+3,355
| +2% | +$208K | 3.48% | 16 |
|
|
2020
Q3 | $12.4M | Buy |
205,538
+5,540
| +3% | +$334K | 3.98% | 12 |
|
|
2020
Q2 | $11.8M | Buy |
199,998
+95
| +0% | +$5.59K | 4.24% | 6 |
|
|
2020
Q1 | $11.1M | Buy |
199,903
+18,433
| +10% | +$1.03M | 4.74% | 3 |
|
|
2019
Q4 | $11.6M | Buy |
181,470
+2,005
| +1% | +$129K | 4.33% | 4 |
|
|
2019
Q3 | $9.1M | Buy |
179,465
+2,620
| +1% | +$133K | 3.72% | 16 |
|
|
2019
Q2 | $8.02M | Buy |
+176,845
| New | +$8.02M | 3.31% | 22 |
|